57 related articles for article (PubMed ID: 9067541)
41. Control of lymphocyte function through CD27-CD70 interactions.
Lens SM; Tesselaar K; van Oers MH; van Lier RA
Semin Immunol; 1998 Dec; 10(6):491-9. PubMed ID: 9826582
[TBL] [Abstract][Full Text] [Related]
42. CD27 and CD70 in T cell and B cell activation.
Borst J; Hendriks J; Xiao Y
Curr Opin Immunol; 2005 Jun; 17(3):275-81. PubMed ID: 15886117
[TBL] [Abstract][Full Text] [Related]
43. New emerging targets in cancer immunotherapy: CD27 (TNFRSF7).
Starzer AM; Berghoff AS
ESMO Open; 2020 Mar; 4(Suppl 3):e000629. PubMed ID: 32152062
[TBL] [Abstract][Full Text] [Related]
44. Subsets of human natural killer cells and their regulatory effects.
Fu B; Tian Z; Wei H
Immunology; 2014 Apr; 141(4):483-9. PubMed ID: 24303897
[TBL] [Abstract][Full Text] [Related]
45. The CD70-CD27 axis in oncology: the new kids on the block.
Flieswasser T; Van den Eynde A; Van Audenaerde J; De Waele J; Lardon F; Riether C; de Haard H; Smits E; Pauwels P; Jacobs J
J Exp Clin Cancer Res; 2022 Jan; 41(1):12. PubMed ID: 34991665
[TBL] [Abstract][Full Text] [Related]
46. The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy.
Buchan SL; Rogel A; Al-Shamkhani A
Blood; 2018 Jan; 131(1):39-48. PubMed ID: 29118006
[TBL] [Abstract][Full Text] [Related]
47. Hypermutation in human B cells in vivo and in vitro.
Weller S; Faili A; Aoufouchi S; Guéranger Q; Braun M; Reynaud CA; Weill JC
Ann N Y Acad Sci; 2003 Apr; 987():158-65. PubMed ID: 12727635
[TBL] [Abstract][Full Text] [Related]
48. Reciprocal expression of CD70 and of its receptor, CD27, in human long term-activated T and natural killer (NK) cells: inverse regulation by cytokines and role in induction of cytotoxicity.
Orengo AM; Cantoni C; Neglia F; Biassoni R; Ferrini S
Clin Exp Immunol; 1997 Mar; 107(3):608-13. PubMed ID: 9067541
[TBL] [Abstract][Full Text] [Related]
49. Plasma cell generation from B-lymphocytes via CD27/CD70 interaction.
Agematsu K; Hokibara S; Nagumo H; Shinozaki K; Yamada S; Komiyama A
Leuk Lymphoma; 1999 Oct; 35(3-4):219-25. PubMed ID: 10706444
[TBL] [Abstract][Full Text] [Related]
50. CD27/CD70 interactions regulate T dependent B cell differentiation.
Jacquot S
Immunol Res; 2000; 21(1):23-30. PubMed ID: 10803880
[TBL] [Abstract][Full Text] [Related]
51. CD27: marker and mediator of T-cell activation?
Hintzen RQ; de Jong R; Lens SM; van Lier RA
Immunol Today; 1994 Jul; 15(7):307-11. PubMed ID: 8086099
[TBL] [Abstract][Full Text] [Related]
52. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.
Nolte MA; van Olffen RW; van Gisbergen KP; van Lier RA
Immunol Rev; 2009 May; 229(1):216-31. PubMed ID: 19426224
[TBL] [Abstract][Full Text] [Related]
53. CD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growth.
Lens SM; de Jong R; Hintzen RQ; Koopman G; van Lier RA; van Oers RH
Leuk Lymphoma; 1995 Jun; 18(1-2):51-9. PubMed ID: 8580829
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
